| Product Code: ETC8390576 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Montenegro Lumasiran Market Overview |
3.1 Montenegro Country Macro Economic Indicators |
3.2 Montenegro Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Montenegro Lumasiran Market - Industry Life Cycle |
3.4 Montenegro Lumasiran Market - Porter's Five Forces |
3.5 Montenegro Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Montenegro Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Montenegro Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Montenegro Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Montenegro Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Montenegro Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Montenegro Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases like primary hyperoxaluria type 1 (PH1) in Montenegro |
4.2.2 Rising awareness about RNAi therapeutics and their effectiveness in treating rare diseases |
4.2.3 Supportive government initiatives and policies for the development and commercialization of orphan drugs |
4.3 Market Restraints |
4.3.1 High costs associated with the development and production of RNAi therapeutics |
4.3.2 Stringent regulatory requirements for approval of orphan drugs in Montenegro |
5 Montenegro Lumasiran Market Trends |
6 Montenegro Lumasiran Market, By Types |
6.1 Montenegro Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Montenegro Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Montenegro Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Montenegro Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Montenegro Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Montenegro Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Montenegro Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Montenegro Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Montenegro Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Montenegro Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Montenegro Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Montenegro Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Montenegro Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Montenegro Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Montenegro Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Montenegro Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Montenegro Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Montenegro Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Montenegro Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Montenegro Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Montenegro Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Montenegro Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Montenegro Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Montenegro Lumasiran Market Import-Export Trade Statistics |
7.1 Montenegro Lumasiran Market Export to Major Countries |
7.2 Montenegro Lumasiran Market Imports from Major Countries |
8 Montenegro Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in Montenegro |
8.2 Adoption rate of lumasiran as a treatment option for PH1 in Montenegro |
8.3 Number of healthcare professionals trained in the administration of lumasiran |
9 Montenegro Lumasiran Market - Opportunity Assessment |
9.1 Montenegro Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Montenegro Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Montenegro Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Montenegro Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Montenegro Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Montenegro Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Montenegro Lumasiran Market - Competitive Landscape |
10.1 Montenegro Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Montenegro Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here